Clinical Trial Update: Intravenous Ancrod for the Treatment of Acute Ischemic Stroke Within 6 Hours After Onset of Symptoms [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update reports completion of intravenous ancrod testing for acute ischemic stroke when administered within 6 hours of symptom onset.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Ischemia
• Stroke

Drugs mentioned

• Ancrod (ancrod)

Snippet

Sponsor: Heidelberg University | Conditions: Brain Infarction, Cerebral Ischemia | Phase 3 | Status: COMPLETED